Spectrum Pharmaceuticals (SPPI) 10-K2012 FY Annual report

Filed: 28 Feb 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abetted, adequacy, affirmative, aided, Aktiengesellschaft, Alamo, ALCL, alisertib, AMAG, AmerisourceBergen, analogue, anaplastic, ancillary, annum, antitumor, Anton, arrive, Atlanta, Authorisation, Beecham, BELIEF, borrow, bound, brentuximab, bulk, captioned, captionedKeucher, captionedRadmore, Cayman, Chancery, CHMP, CKD, Complaint, complementary, complimentary, confirmatory, convene, Corixa, Coulter, covenant, CTCL, cultural, deal, defective, denial, denominated, desease, DHFR, differential, diffuse, digit, dihydrofolate, dismissed, distance, downsizing, doxorubicin, drew, eighty, EMA, era, error, Fargo, fiduciary, fifteen, floor, flower, FOLOTYN, folypolyglutamyl, forma, Gagnon, Georgia, Glaxo, Glioblastoma, guaranty, Gueth, halt, Hamni, hundred, hyperphospaternia, ibritumomab, inactivated, incorrect, incremental, inexperience, inside, Interbank, interfering, intracellular, Jersey, Keller, Keucher, lag, leaseback, lender, LIBOR, likelihood, lived, living, loan, MAA, man, mechanism, memorandum, Michigan, middle, migrate, misleading, molecule, MOU, Multiforme, Mundipharma, noncompliance, nucleic, orrefractory, pathway, PDX, polyglutamylate, polyglutamylated, polyglutamylation, poster, pralatrexate, preferentially, preliminary, printing, proceed, profitablity, protein, provisional, purine, pyrimidine, qualitative, radiosensitizing, Radmore, reacquire, reacquired, red, reductase, referenced, refusal, reinstated, reinstatement, relief, relieved, Reorganization, repaid, repatriation, revolving, RFC, RNA, romidepsin, Sapphire, Seattle, Sequential, SmithKline, social, SRI, stipulation, suggest, surpassing, synthetase, Taxpayer, Tokyo, translate, translated, translation, transport, transportation, transurethral, uncured, undertook, unencumbered, unidentified, unreasonable, unused, USD, vedotin, Village, warehousing, Westlake, XBRL, yearly

Removed: acute, aforementioned, asserting, audience, bearing, billed, biopharmaceutical, budgetary, carboplatin, certainty, chairman, checking, conservative, corrective, credited, damaging, declaring, demonstrative, destruction, dispensing, disposing, disseminate, exacerbate, failed, impacting, imply, insignificant, judged, Kumaria, marketer, modified, Montreal, multicenter, municipal, opposition, permanent, personal, pool, prepare, presently, prevail, prohibiting, propose, prosecute, reauthorizing, reclassify, recordkeeping, redeeming, refund, register, relaxation, remedial, remediation, restrict, satraplatin, sector, shift, Shyam, Switzerland, tendered, till, topic, turnover, type, unapproved, unit, validation, window, Zurich

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

SPPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-163366, 333-150260, 333-142628, 333-135029, 333-125208, 333-121612, 333-115759, 333-110103, 333-108658, 333-105814, 333-102587, 333-64444, 333-64432, 333-60966, 333-51388, 333-42852, 333-38710, 333-37180, 333-92855, 333-73009, 333-52331, 333-37585, 333-185115; and Form S-8 Nos. 333-176681, 333-160312, 333-160705, 333-164014, 333-134566, 333-119833, 333-106427, 333-54246, 333-30345)) of Spectrum Pharmaceuticals, Inc. and Subsidiaries and in the related Prospectuses of our reports dated February 27, 2013, with respect to the consolidated financial statements of Spectrum Pharmaceuticals, Inc. and Subsidiaries, and the effectiveness of internal control over financial reporting of Spectrum Pharmaceuticals, Inc. and Subsidiaries, included in this Annual Report (Form 10-K) for the year ended December 31, 2012.

/s/ Ernst & Young LLP

Irvine, California

February 27, 2013